CBC Group and Mubadala acquire UCB's mature neurology and allergy business in China for US$680 million. New company is named NeuroGen Pharma, led by an experienced management team with a strong track ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback